Our highly metastatic TM40D-MB (CD1d-lo) tumor cells actually grow slower than TM40D (CD1d-hi) cells, both in vitro (unpublished data) and in vivo, and modulation of tumor CD1d expression by either antibody blockade or gene knockdown had no effect on primary tumor growth. The gene discussed is CD1D; the disease is neoplasm.